OS Therapies Inc
Data quality: 83%
OSTX
NYSE
Manufacturing
Chemicals
$1.34
▲
$0.09
(6.80%)
Mkt Cap: 54.02 M
Price
$1.34
Mkt Cap
54.02 M
Day Range
$1.23 — $1.35
52-Week Range
$1.12 — $2.57
Volume
1,156,591
Open $1.25
50D / 200D Avg
$1.40
4.34% below
50D / 200D Avg
$1.74
23.09% below
Quick Summary
Key Takeaways
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -14.24 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-670.19%
Below sector avg (-53.41%)
ROIC-382.41%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.03
Below sector avg (0.31)
Current Ratio0.56
Interest Coverage-13.99
Valuation
PE (TTM)
-1.88
Below sector avg (-1.48)
P/B Ratio14.85
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.9 | -1.5 |
| P/B | 14.9 | 1.6 |
| ROE % | -670.2 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | 0.0 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -28.75 M |
| ROE | -670.19% | ROA | -298.53% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -14.24 M |
| ROIC | -382.41% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 0.56 |
| Interest Coverage | -13.99 | Asset Turnover | N/A |
| Working Capital | -1.82 M | Tangible Book Value | -3.23 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.88 | Forward P/E | N/A |
| P/B Ratio | 14.85 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -26.36% | ||
| Market Cap | 54.02 M | Enterprise Value | 54.12 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.98 | Revenue / Share | N/A |
| FCF / Share | -0.35 | OCF / Share | -0.35 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 49.52% |
| SBC-Adj. FCF | -16.90 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | -28.75 M | -8.88 M |
| EPS (Diluted) | -0.98 | -0.88 |
| Gross Profit | — | — |
| Operating Income | -28.71 M | -6.81 M |
| EBITDA | — | — |
| R&D Expenses | 16.36 M | 2.84 M |
| SG&A Expenses | — | — |
| D&A | 363,085.0 | — |
| Interest Expense | 2.05 M | 2.05 M |
| Income Tax | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 6.84 M | 5.54 M |
| Total Liabilities | 11.86 M | 4.73 M |
| Shareholders' Equity | -6.10 M | -5.24 M |
| Total Debt | 100,000.0 | 100,000.0 |
| Cash & Equivalents | — | — |
| Current Assets | 332,912.0 | 5.53 M |
| Current Liabilities | 11.76 M | 4.63 M |
{"event":"ticker_viewed","properties":{"ticker":"OSTX","listing_kind":"stock","pathname":"/stocks/ostx","exchange":"NYSE","country":"US"}}